ft 04 jan 94 green light new drug enter big us market drug potenti annual sale hundr million dollar approv sale us last week food drug administr among compani whose product clear final hurdl smithklin beecham uk bayer germani genentech us biotechnolog compani 60 per cent own roch switzerland success us market essenti fortun new drug us easili world biggest drug market account third global sale genentech drug dnase first product 30 year specif develop treat cystic fibrosi inherit lung diseas cure diseas fda found made signific differ qualiti life suffer dnase like one biggest sell product biotechnolog compani us stockbrok lehman brother estim sale dollar 250m pound 169m year smithklin beecham saw approv kytril prevent nausea vomit associ cancer therapi kytril enter rapidli grow lucr market howev compet zofran made glaxo two year head start us market avail easier use tablet version zofran alreadi sale pound 300m year tablet version kytril unlik approv 1995 said mr duncan moor pharmaceut analyst us broker morgan stanley bayer newli approv drug aprontonin reduc need blood transfus patient undergo heart bypass surgeri fewer transfus cut chanc infect compani saw approv last day 1993 bristol myer us dovonex ointment treatment skin condit psoriasi warner lambert us neurontin anti epilept wyeth us effexor depress treatment us bioscienc neutrexin altern therapi pneumonia associ aid janssen belgian subsidiari us compani johnson amp johnson risperd psychosi drug